LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

LLY

997.3

-0.85%↓

JNJ

241.92

-1.04%↓

ABBV

227.18

-0.36%↓

NVS

155.4

-4.26%↓

AZN

193.33

-1.76%↓

Search

Integra LifeSciences Holdings Corp

Deschisă

SectorSănătate

9.58 -1.03

Rezumat

Modificarea prețului

24h

Curent

Minim

9.2

Maxim

9.76

Indicatori cheie

By Trading Economics

Venit

3.7M

-1.7M

Vânzări

33M

435M

Marjă de profit

-0.392

Angajați

4,427

EBITDA

12M

66M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+25.39% upside

Dividende

By Dow Jones

Următoarele câștiguri

4 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-170M

746M

Deschiderea anterioară

10.61

Închiderea anterioară

9.58

Sentimentul știrilor

By Acuity

100%

0%

330 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 mar. 2026, 20:38 UTC

Câștiguri

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

10 mar. 2026, 23:57 UTC

Market Talk

Global Equities Roundup: Market Talk

10 mar. 2026, 23:57 UTC

Market Talk

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

10 mar. 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

10 mar. 2026, 23:37 UTC

Achiziții, Fuziuni, Preluări

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

10 mar. 2026, 23:35 UTC

Market Talk
Evenimente importante

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

10 mar. 2026, 23:06 UTC

Câștiguri

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

10 mar. 2026, 22:51 UTC

Evenimente importante

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

10 mar. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

10 mar. 2026, 21:21 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

10 mar. 2026, 21:15 UTC

Câștiguri

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

10 mar. 2026, 21:15 UTC

Achiziții, Fuziuni, Preluări

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

10 mar. 2026, 21:14 UTC

Câștiguri

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

10 mar. 2026, 21:13 UTC

Câștiguri

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

10 mar. 2026, 21:12 UTC

Câștiguri

Franco-Nevada 4Q Rev $597.3M >FNV

10 mar. 2026, 21:12 UTC

Câștiguri

Franco-Nevada 4Q EPS $1.90

10 mar. 2026, 20:57 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:50 UTC

Market Talk
Câștiguri

Tech, Media & Telecom Roundup: Market Talk

10 mar. 2026, 20:44 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:34 UTC

Market Talk
Câștiguri

Global Equities Roundup: Market Talk

10 mar. 2026, 20:34 UTC

Market Talk
Câștiguri

Oracle Building More Software for Less Money After Restructuring -- Market Talk

10 mar. 2026, 20:23 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

10 mar. 2026, 20:16 UTC

Câștiguri

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

10 mar. 2026, 20:14 UTC

Câștiguri

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

10 mar. 2026, 20:14 UTC

Câștiguri

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

10 mar. 2026, 20:13 UTC

Câștiguri

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

10 mar. 2026, 20:12 UTC

Câștiguri

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Comparație

Modificare preț

Integra LifeSciences Holdings Corp Așteptări

Obiectiv de preț

By TipRanks

25.39% sus

Prognoză pe 12 luni

Medie 12 USD  25.39%

Maxim 13 USD

Minim 11 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIntegra LifeSciences Holdings Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

0

Cumpărare

3

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

12.75 / 16.41Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

330 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat